Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04419389 |
|---|---|
| Brief Title: | APR-246 in Combination With Ibrutinib or Venetoclax-R in Subjects With TP53-Mutant R/R Non Hodgkin Lymphomas (NHL) (R/R) |
| First Submitted : | June 1, 2020 |
| First Submitted that Met QC Criteria : | June 3, 2020 |
| First Posted : | June 5, 2020 |
| Last Update Submitted that Met QC Criteria : | January 14, 2021 |
| Last Update Posted : | January 19, 2021 |